Randomized Investigation of Heart Failure Therapy in Patients with Advanced Cancer at Risk of Cardiac Wasting: Rationale and Design of the EMPATICC Trial

20254 citationsJournal Articlehybrid Open Access

Authors

EMPATICC evaluates whether HF therapy can improve function and well-being in advanced cancer, potentially reshaping care in this population.

Published in: European Journal of Heart Failure

Volume 27, Issue 10, pp. 1905-1917

Field-Weighted Citation Impact: 5.62